| abstract |
A form of transdermal or transmucosal pharmaceutical presentation for the treatment of nicotine dependence or for smoking cessation, containing nicotine, a nicotine salt, a nicotinic derivative or a substance of nicotinergic action in combination with at least one other active substance , characterized by containing as an additional active principle (s) at least one substance that acts on the central nervous system. |